Cadre Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 33.4
- Dividend yield
- 1.40%
About Cadre
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Cadre Holdings manufactures and distributes safety and protective equipment for emergency response, defense, and nuclear sectors. Its product offerings include body armor, bomb disposal suits, duty holsters, officer gear, blast sensors, and robotics. For the nuclear industry, the company provides containment systems, radioactive material storage containers, remote handling equipment, and engineering services. Cadre serves municipal, state, and federal law enforcement agencies, military branches, fire and rescue units, and commercial nuclear facilities.
The company is headquartered in Jacksonville, Florida, and operates manufacturing and research facilities across North America and Europe, including sites in the United States, Canada, the United Kingdom, Germany, and Lithuania. Cadre employs 2,533 individuals worldwide and distributes products to more than 100 countries. It maintains relationships with over 23,000 emergency responders and public agencies through internal sales personnel and dedicated distribution networks.
Summary of the business section of Cadre's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Cadre Holdings, Inc.
- Founded
- 1964
- Headquarters
- Jacksonville, FL
- Address
- 13386 International Pkwy 32218
- Phone
- (904) 741-5400
- Website
- cadre-holdings.com
- Employees
- 2,533, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, Jacksonville, Florida
Stock & identifiers
- Ticker
- CDRE
- Exchange
- NYSE
- IPO date
- Nov 5, 2021
- Shares outstanding
- 43M, Jul 31, 2026
- Public float
- $577.50M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1860543
- CUSIP
- 12763L105
- ISIN
- US12763L1052
- LEI
- 2549006IKQEWJ8M7CB97
- EIN
- 38-3873146
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Warren B. Kanders | CEO AND CHAIRMAN, Director | 10,813,682 |
| Brad Williams | PRESIDENT | 107,851 |
| Blaine Browers | CHIEF FINANCIAL OFFICER | 70,945 |
| Hamish Norton | Director | 23,500 |
| Nicolas Sokolow | Director | 333,578 |
| William G. Quigley Iii | Director | 23,500 |
| Mary E. Kissel | Director | 0 |
| Gianmaria C. Delzanno | Director | 0 |
| Deborah A. DeCotis | Director | 0 |
Employees
Headcount reported in annual reports
“We have a total of 2,533 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 30, 2026 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| May 5, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 5, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 29, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| Jul 30, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |